Evidence map›Paper›PMID 37456463›Full record

ReviewCureus2023

The Role of Sirtuin 1 (SIRT1) in Neurodegeneration.

Daniel I Razick, Muzammil Akhtar, Jimmy Wen, Meraj Alam, Nabeal Dean, Muhammad Karabala, Ubaid Ansari, Zaid Ansari, Ethan Tabaie, Shakeel Siddiqui

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Daniel I RazickSurgery, California Northstate University College of Medicine, Elk Grove, USA.
Muzammil AkhtarSurgery, California Northstate University College of Medicine, Elk Grove, USA.
Jimmy WenPhysical Medicine and Rehabilitation, California Northstate University College of Medicine, Elk Grove, USA.
Meraj AlamInternal Medicine, California Northstate University College of Medicine, Elk Grove, USA.
Nabeal DeanInternal Medicine, California Northstate University College of Medicine, Elk Grove, USA.
Muhammad KarabalaInternal Medicine, California Northstate University College of Medicine, Elk Grove, USA.
Ubaid AnsariInternal Medicine, California Northstate University College of Medicine, Elk Grove, USA.
Zaid AnsariInternal Medicine, University of California Berkeley, Berkeley, USA.
Ethan TabaieNeurosurgery, California Northstate University College of Medicine, Elk Grove, USA.
Shakeel SiddiquiAnesthesiology, OrthoMed Staffing Anesthesiology Group, Dallas, USA.
Dallas Surgical Group · USUniversity of California, Berkeley · USCalifornia Northstate University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sirtuins (SIRT) are a class of histone deacetylases that regulate important metabolic pathways and play a role in several disease processes. Of the seven mammalian homologs currently identified, sirtuin 1 (SIRT1) is the best understood and most studied. It has been associated with several neurodegenerative diseases and cancers. As such, it has been further investigated as a therapeutic target in the treatment of disorders such as Parkinson's disease (PD), Huntington's disease (HD), and Alzheimer's disease (AD). SIRT1 deacetylates histones such as H1 lysine 26, H3 lysine 9, H3 lysine 56, and H4 lysine 16 to regulate chromatin remodeling and gene transcription. The homolog has also been observed to express contradictory responses to tumor suppression and tumor promotion. Studies have shown that SIRT1 may have anti-inflammatory properties by inhibiting the effects of NF-κB, as well as stimulating upregulation of autophagy. The SIRT1 activators resveratrol and cilostazol have been shown to improve Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) scores in AD patients. In this review, we aim to explore the various roles of SIRT1 with regard to neuroprotection and neurodegeneration.

Indexed as

alzheimer's diseasehistone deacetylase (hdac)neurodegenerationneurological diseasessirtuin 1

Identifiers

PMID37456463
PMCPMC10349546
OpenAlexW4380998203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.